These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33857426)

  • 1. Partial protection against P. vivax infection diminishes hypnozoite burden and blood-stage relapses.
    Schäfer C; Dambrauskas N; Reynolds LM; Trakhimets O; Raappana A; Flannery EL; Roobsoong W; Sattabongkot J; Mikolajczak SA; Kappe SHI; Sather DN
    Cell Host Microbe; 2021 May; 29(5):752-756.e4. PubMed ID: 33857426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice.
    Mikolajczak SA; Vaughan AM; Kangwanrangsan N; Roobsoong W; Fishbaugher M; Yimamnuaychok N; Rezakhani N; Lakshmanan V; Singh N; Kaushansky A; Camargo N; Baldwin M; Lindner SE; Adams JH; Sattabongkot J; Kappe SH
    Cell Host Microbe; 2015 Apr; 17(4):526-35. PubMed ID: 25800544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium vivax pre-erythrocytic stages and the latent hypnozoite.
    Zanghi G; Vaughan AM
    Parasitol Int; 2021 Dec; 85():102447. PubMed ID: 34474178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical Implications of a Pre-Erythrocytic Plasmodium vivax Vaccine for Preventing Relapses.
    White M; Amino R; Mueller I
    Trends Parasitol; 2017 Apr; 33(4):260-263. PubMed ID: 28077251
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Schäfer C; Zanghi G; Vaughan AM; Kappe SHI
    Annu Rev Microbiol; 2021 Oct; 75():87-106. PubMed ID: 34196569
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation of the hypnozoite: a part of Plasmodium vivax life cycle and survival.
    Hulden L; Hulden L
    Malar J; 2011 Apr; 10():90. PubMed ID: 21496287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission.
    White MT; Karl S; Battle KE; Hay SI; Mueller I; Ghani AC
    Elife; 2014 Nov; 3():. PubMed ID: 25406065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals.
    Chen N; Auliff A; Rieckmann K; Gatton M; Cheng Q
    J Infect Dis; 2007 Apr; 195(7):934-41. PubMed ID: 17330782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium vivax liver stage assay platforms using Indian clinical isolates.
    Subramani PA; Vartak-Sharma N; Sreekumar S; Mathur P; Nayer B; Dakhore S; Basavanna SK; Kalappa DM; Krishnamurthy RV; Mukhi B; Mishra P; Yoshida N; Ghosh SK; Shandil R; Narayanan S; Campo B; Hasegawa K; Anvikar AR; Valecha N; Sundaramurthy V
    Malar J; 2020 Jun; 19(1):214. PubMed ID: 32571333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of relapse periodicity in Plasmodium vivax malaria.
    White NJ
    Malar J; 2011 Oct; 10():297. PubMed ID: 21989376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.
    Roth A; Maher SP; Conway AJ; Ubalee R; Chaumeau V; Andolina C; Kaba SA; Vantaux A; Bakowski MA; Thomson-Luque R; Adapa SR; Singh N; Barnes SJ; Cooper CA; Rouillier M; McNamara CW; Mikolajczak SA; Sather N; Witkowski B; Campo B; Kappe SHI; Lanar DE; Nosten F; Davidson S; Jiang RHY; Kyle DE; Adams JH
    Nat Commun; 2018 May; 9(1):1837. PubMed ID: 29743474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling Plasmodium vivax: relapses, treatment, seasonality, and G6PD deficiency.
    Chamchod F; Beier JC
    J Theor Biol; 2013 Jan; 316():25-34. PubMed ID: 22959914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium vivax pre-erythrocytic-stage antigen discovery: exploiting naturally acquired humoral responses.
    Molina DM; Finney OC; Arevalo-Herrera M; Herrera S; Felgner PL; Gardner MJ; Liang X; Wang R
    Am J Trop Med Hyg; 2012 Sep; 87(3):460-9. PubMed ID: 22826492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass Spectrometry Identification of Biomarkers in Extracellular Vesicles From Plasmodium vivax Liver Hypnozoite Infections.
    Gualdrón-López M; Díaz-Varela M; Zanghi G; Aparici-Herraiz I; Steel RWJ; Schäfer C; Cuscó P; Chuenchob V; Kangwangransan N; Billman ZP; Olsen TM; González JR; Roobsoong W; Sattabongkot J; Murphy SC; Mikolajczak SA; Borràs E; Sabidó E; Fernandez-Becerra C; Flannery EL; Kappe SHI; Del Portillo HA
    Mol Cell Proteomics; 2022 Oct; 21(10):100406. PubMed ID: 36030044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypnozoite dynamics for Plasmodium vivax malaria: The epidemiological effects of radical cure.
    Mehra S; Stadler E; Khoury D; McCaw JM; Flegg JA
    J Theor Biol; 2022 Mar; 537():111014. PubMed ID: 35016895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Analyses Reveal the Common Occurrence and Complexity of
    Popovici J; Friedrich LR; Kim S; Bin S; Run V; Lek D; Cannon MV; Menard D; Serre D
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362233
    [No Abstract]   [Full Text] [Related]  

  • 17. In Vitro Culture, Drug Sensitivity, and Transcriptome of Plasmodium Vivax Hypnozoites.
    Gural N; Mancio-Silva L; Miller AB; Galstian A; Butty VL; Levine SS; Patrapuvich R; Desai SP; Mikolajczak SA; Kappe SHI; Fleming HE; March S; Sattabongkot J; Bhatia SN
    Cell Host Microbe; 2018 Mar; 23(3):395-406.e4. PubMed ID: 29478773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The march toward malaria vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Activation-Clearance Model for Plasmodium vivax Malaria.
    Mehra S; McCaw JM; Flegg MB; Taylor PG; Flegg JA
    Bull Math Biol; 2020 Feb; 82(2):32. PubMed ID: 32052192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypnozoite depletion in successive Plasmodium vivax relapses.
    Noviyanti R; Carey-Ewend K; Trianty L; Parobek C; Puspitasari AM; Balasubramanian S; Park Z; Hathaway N; Utami RAS; Soebianto S; Jeny J; Yudhaputri F; Perkasa A; Coutrier FN; Tirta YK; Ekawati L; Tjahyono B; Sutanto I; Nelwan EJ; Sudoyo H; Baird JK; Lin JT
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010648. PubMed ID: 35867730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.